199 related articles for article (PubMed ID: 31839435)
1. Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study.
Procopio F; Viganò L; Cimino M; Donadon M; Del Fabbro D; Torzilli G
Eur J Surg Oncol; 2020 May; 46(5):818-824. PubMed ID: 31839435
[TBL] [Abstract][Full Text] [Related]
2. Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort.
Viganò L; Procopio F; Cimino MM; Donadon M; Gatti A; Costa G; Del Fabbro D; Torzilli G
Ann Surg Oncol; 2016 Apr; 23(4):1352-60. PubMed ID: 26714946
[TBL] [Abstract][Full Text] [Related]
3. The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin.
Viganò L; Branciforte B; Laurenti V; Costa G; Procopio F; Cimino M; Del Fabbro D; Di Tommaso L; Torzilli G
Ann Surg Oncol; 2022 Sep; 29(9):5515-5524. PubMed ID: 35687176
[TBL] [Abstract][Full Text] [Related]
4. Oncological outcome of R1 vascular margin for mass-forming cholangiocarcinoma. A single center observational cohort analysis.
Torzilli G; Viganò L; Fontana A; Procopio F; Terrone A; Cimino MM; Donadon M; Del Fabbro D
HPB (Oxford); 2020 Apr; 22(4):570-577. PubMed ID: 31530450
[TBL] [Abstract][Full Text] [Related]
5. KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.
Zhang Q; Peng J; Ye M; Weng W; Tan C; Ni S; Huang D; Sheng W; Wang L
Ann Surg Oncol; 2020 Apr; 27(4):1164-1173. PubMed ID: 31720935
[TBL] [Abstract][Full Text] [Related]
6. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
7. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
[TBL] [Abstract][Full Text] [Related]
8. Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.
Margonis GA; Sasaki K; Kim Y; Samaha M; Buettner S; Amini N; Antoniou E; Pawlik TM
J Gastrointest Surg; 2016 Nov; 20(11):1821-1829. PubMed ID: 27384430
[TBL] [Abstract][Full Text] [Related]
9. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.
Shindoh J; Nishioka Y; Yoshioka R; Sugawara T; Sakamoto Y; Hasegawa K; Hashimoto M; Kokudo N
Ann Surg Oncol; 2016 Jun; 23(6):1890-6. PubMed ID: 26786089
[TBL] [Abstract][Full Text] [Related]
10. KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.
Margonis GA; Sasaki K; Andreatos N; Kim Y; Merath K; Wagner D; Wilson A; Buettner S; Amini N; Antoniou E; Pawlik TM
Ann Surg Oncol; 2017 Jan; 24(1):264-271. PubMed ID: 27696170
[TBL] [Abstract][Full Text] [Related]
11. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.
Nishioka Y; Paez-Arango N; Boettcher FO; Kawaguchi Y; Newhook TE; Chun YS; Tzeng CD; Tran Cao HS; Lee JE; Vreeland TJ; Vauthey JN
J Gastrointest Surg; 2022 Apr; 26(4):791-801. PubMed ID: 34725784
[TBL] [Abstract][Full Text] [Related]
12. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
13. The Impact of KRAS Status on the Required Surgical Margin Width for Colorectal Liver Metastasis Resection.
Iwaki K; Kaihara S; Koyama T; Nakao K; Matsuda S; Toriguchi K; Kitamura K; Oshima N; Kondo M; Hashida H; Kobayashi H; Uryuhara K
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983314
[TBL] [Abstract][Full Text] [Related]
14. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
[TBL] [Abstract][Full Text] [Related]
15. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
[TBL] [Abstract][Full Text] [Related]
16. R1 Vascular or Parenchymal Margins: What Is the Impact after Resection of Intrahepatic Cholangiocarcinoma?
Mabilia A; Mazzotta AD; Robin F; Ghallab M; Vibert E; Adam R; Cherqui D; Cunha AS; Azoulay D; Salloum C; Pittau G; Ciacio O; Allard MA; Boudjema K; Sulpice L; Golse N
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291934
[No Abstract] [Full Text] [Related]
17. R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.
Viganò L; Costa G; Cimino MM; Procopio F; Donadon M; Del Fabbro D; Belghiti J; Kokudo N; Makuuchi M; Vauthey JN; Torzilli G
J Gastrointest Surg; 2018 Oct; 22(10):1752-1763. PubMed ID: 29948554
[TBL] [Abstract][Full Text] [Related]
18. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
[TBL] [Abstract][Full Text] [Related]
19. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
[TBL] [Abstract][Full Text] [Related]
20. Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.
Donadon M; Terrone A; Procopio F; Cimino M; Palmisano A; Viganò L; Del Fabbro D; Di Tommaso L; Torzilli G
Surgery; 2019 May; 165(5):897-904. PubMed ID: 30691871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
